Evidence map›Paper›PMID 42619975›Full record

ArticleResearch square2026

Machine learning approaches for tuberculosis prevalence and risk factor association among high-risk groups in Kigali health facilities.

Theophilla Igihozo, Fiacre Rugamba Rugero, Emma Marie Umutoniwase, Emelie Ndoli, Emmanuel Niyonshuti, Rwubaka Eugene, Emmanuel Sibomana, Melissa Uwase, Dieudonne Kayiranga, Michael Mugisha and 9 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Theophilla IgihozoCollege of Medicine and Health Sciences, University of Rwanda.
Fiacre Rugamba RugeroCollege of Medicine and Health Sciences, University of Rwanda.
Emma Marie UmutoniwaseCollege of Medicine and Health Sciences, University of Rwanda.
Emelie NdoliCollege of Medicine and Health Sciences, University of Rwanda.
Emmanuel NiyonshutiCollege of Medicine and Health Sciences, University of Rwanda.
Rwubaka EugeneCollege of Medicine and Health Sciences, University of Rwanda.
Emmanuel SibomanaCollege of Business and Economics, University of Rwanda.
Melissa UwaseCollege of Medicine and Health Sciences, University of Rwanda.
Dieudonne KayirangaCollege of Medicine and Health Sciences, University of Rwanda.
Michael MugishaCollege of Medicine and Health Sciences, University of Rwanda.
Celestin TwizereHealth Informatics, Regional Center of Excellence in Biomedical Engineering & E-Health, University of Rwanda, Kigali Innovation City.
Isambi Sailon MbalawataAfrican Institute for Mathematical Sciences Research and Innovation Centre.
Davila-Roman VictorSchool of Medicine, Washington University in St. Louis, St. Louis.
Adams WilcoxSchool of Medicine, Washington University in St. Louis, St. Louis.
Randi ForakerSchool of Medicine, University of Missouri, Columbia.
Isaac GominaSchool of Medicine, University of Missouri, Columbia.
Michelle SchneiderInstitute for Informatics, Data Science and Biostatistics, Washington University in St. Louis, St. Louis.
David TumusiimeCollege of Medicine and Health Sciences, University of Rwanda.
Emmy MugishaHealth Informatics, Regional Center of Excellence in Biomedical Engineering & E-Health, University of Rwanda, Kigali Innovation City.

Funding

Research Training in Data Science for Health in RwandaU2RTW012122 · FIC · WASHINGTON UNIVERSITY · PI Victor G. Davila-Roman, David Tumusiime · 2021 to 2026
$1.9M
SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")UE5HL172181 · NHLBI · NATIONAL UNIVERSITY OF RWANDA · PI DAVILA-ROMAN, VICTOR G., FORAKER, RANDI E · 2023 to 2025
$599k
FIC NIH HHS U2R TW012122NHLBI NIH HHS UE5 HL172181
6 · The paper itself

Abstract

Background: Tuberculosis (TB) remains a major global health challenge, disproportionately affecting vulnerable populations in resource-limited settings. In Rwanda, the burden is high among high-risk groups including prisoners, mining workers, people living with HIV, and healthcare workers. Despite well-established national surveillance infrastructure, published evidence on applying machine learning (ML) to routinely collected electronic medical records (EMR) for identifying factors associated with TB in these populations remains limited. This study develops and compares multiple ML models to identify factors associated with TB among high-risk groups using national surveillance data from Kigali health facilities, while emphasizing careful feature engineering to avoid information leakage. Methods: We conducted a retrospective, cross-sectional analysis of 2,254 high-risk patient EMR from Rwanda Biomedical Center (RBC) surveillance systems, with TB status defined by GeneXpert results. Rigorous data cleaning and preprocessing were performed, including exclusion of records with indeterminate outcomes, removal of diagnostic and operational variables that could introduce information leakage, imputation of missing values, normalization of numerical features, and one-hot encoding of categorical variables. Multiple supervised ML models were developed and evaluated using a stratified train-test split, including logistic regression (LR), balanced random forest (BRF), gradient boosting methods (XGBoost, LightGBM, and GBM), support vector machines (SVM) with a radial basis function kernel, and an EasyEnsemble classifier. Model performance was assessed using accuracy, precision, recall, F1-score, and area under the receiver operating characteristic (ROC) curve (AUC). Results: After excluding indeterminate GeneXpert outcomes, 358 cases were retained for evaluation. Ensemble-based models showed consistently strong and stable performance, with BRF achieving the highest discrimination (AUC = 0.86), while GBM, SVM, and EasyEnsemble classifiers showed comparable performance across accuracy, precision, recall, and F1-score. Feature-importance analysis identified clinically meaningful factors, associated with TB, including site of disease, age, TB-related body mass index, HIV status, and diabetes status, indicating that the models relied on plausible biological and demographic risk factors rather than diagnostic artifacts. Conclusions: This first application of EMR-driven ML for identifying TB risk factor associations in Rwanda shows that ensemble models, combined with rigorous leakage control, achieve promising performance among high-risk populations. These tools could support national TB surveillance and screening to enhance early detection and resource allocation.

Indexed as

Electronic Medical RecordsMachine LearningRisk FactorsTuberculosis

Identifiers

PMID42619975
PMCPMC13484438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.